Skip to main content
. Author manuscript; available in PMC: 2019 Aug 9.
Published in final edited form as: J Neuroendocrinol. 2018 Feb 9:10.1111/jne.12582. doi: 10.1111/jne.12582

Table 1.

ANOVA statistics for measures of Fos-ir. Significant effects are bolded.

Play Condition Sex Play Condition X Sex Effects or Interactions with Tissue Series
SO
AVP-ir + Fos-ir F(1,30) = 0.28, p = 0.60 F(1,30) = 4.34, p = 0.047 F(1,30) = 0.067, p = 0.78 n/a
OT-ir + Fos-ir F(1,29) = 0.66, p = 0.43 F(1,29) = 9.54, p = 0.005 F1,29) < 0.10, p = 0.88 n/a
Total Fos-ir F(1,25) = 0.75, p = 0.39 F(1,25) = 6.22, p = 0.020 F(1,25) < 0.10, p = 0.95 F(1,25) < 4.05, p > 0.055, all
% of Total Fos-ir in AVP-ir F(1,30) < 0.10, p = 0.95 F(1,30) = 0.24, p = 0.63 F(1,30) = 0.22, p = 0.64 n/a
% of Total Fos-ir in OT-ir F(1,29) = 0.47, p = 0.50 F(1,29) = 0.72, p = 0.40 F(1,30) = 0.81, p = 0.38 n/a

PVH
Total Fos-ir F(1,26) = 2.45, p = 0.13 F(1,26) = 0.62, p = 0.44 F(1,26) = 0.46, p = 0.51 F(1,26) < 1.25, p > 0.28, all

pBST
Total Fos-ir F(1,29) = 11.3, p = 0.002 F(1,29) = 3.48, p = 0.074 F(1,29) = 3.84, p = 0.061 n/a

MEApd
Total Fos-ir F(1,29) = 11.2, p = 0.003 F(1,29) < 0.10, p = 0.86 F(1,29) = 3.20, p = 0.086 n/a